Search Results - "Fogarty, Charles M."

Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial by Rooks, Daniel, Swan, Therese, Goswami, Budhaditya, Filosa, Lee Anne, Bunte, Ola, Panchaud, Nicolas, Coleman, Laura A, Miller, Ram R, Garcia Garayoa, Elisa, Praestgaard, Jens, Perry, Robert G, Recknor, Chris, Fogarty, Charles M, Arai, Hidenori, Chen, Liang-Kung, Hashimoto, Jun, Chung, Yoon-Sok, Vissing, John, Laurent, Didier, Petricoul, Olivier, Hemsley, Sarah, Lach-Trifilieff, Estelle, Papanicolaou, Dimitris A, Roubenoff, Ronenn

“…The potential benefit of novel skeletal muscle anabolic agents to improve physical function in people with sarcopenia and other muscle wasting diseases is…”
Get full text

Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPD by Chapman, Kenneth R, Fogarty, Charles M, Peckitt, Clare, Lassen, Cheryl, Jadayel, Dalal, Dederichs, Juergen, Dalvi, Mukul, Kramer, Benjamin

“…For optimal efficacy, an inhaler should deliver doses consistently and be easy for patients to use with minimal instruction. The delivery characteristics,…”
Get full text

Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy by Katz, Eric, Larsen, L.Scott, Fogarty, Charles M., Hamed, Kamal, Song, James, Choudhri, Shurjeel

“…To compare the efficacy of sequential i.v. to p.o. moxifloxacin with ceftriaxone ± azithromycin ± metronidazole for the treatment of patients with community…”
Get full text

Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study by Fogarty, Charles M, Patel, Tushar C, Dunbar, Lala M, Leroy, Bruno P

“…Community-acquired pneumonia (CAP) remains a major cause of morbidity and mortality throughout the world. Telithromycin (a new ketolide) has shown good in…”
Get full text

Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin by Fogarty, Charles M., Kohno, Shigeru, Buchanan, Patricia, Aubier, Michel, Baz, Malik

“…The incidence of community-acquired respiratory tract infections caused by Streptococcus pneumoniae exhibiting antibacterial resistance has increased…”
Get full text

POOLED SAFETY RESULTS OVER 24 WEEKS FROM THE ENHANCE PROGRAM WITH ENSIFENTRINE, A NOVEL DUAL PHOSPHODIESTERASE (PDE) 3 AND 4 INHIBITOR by SILER, THOMAS M, FOGARTY, CHARLES M, RHEAULT, TARA, BENGTSSON, THOMAS, ANN RICKARD, KATHLEEN

Get full text

NEBULIZED ENSIFENTRINE IMPROVES LUNG FUNCTION, SYMPTOMS, QUALITY OF LIFE AND REDUCES EXACERBATIONS IN SYMPTOMATIC COPD PATIENTS REGARDLESS OF BACKGROUND LAMA OR LABA THERAPY by SILER, THOMAS M, FOGARTY, CHARLES M, RHEAULT, TARA, BENGTSSON, THOMAS, ANN RICKARD, KATHLEEN

Get full text

A comparison of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of community-acquired pneumonia: A multicenter, prospective, randomized, investigator-blinded, parallel-group study by Fogarty, Charles M., Cyganowski, Marcia, Palo, William A., Hom, Richard C., Craig, William A.

“…Background: Cefditoren pivoxil is a broad-spectrum cephalosporin that is approved for the treatment of pharyngitis, acute exacerbations of chronic bronchitis,…”
Get full text

Telithromycin in the treatment of pneumococcal community-acquired respiratory tract infections: a review by Fogarty, Charles M, Buchanan, Patricia, Aubier, Michel, Baz, Malik, van Rensburg, Dirkie, Rangaraju, Manickam, Nusrat, Roomi

“…A pooled analysis of 14 Phase III studies was performed to establish the clinical and bacteriologic efficacy of telithromycin 800 mg once daily in the…”
Get full text

Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials by Fogarty, Charles M., Greenberg, Richard N., Dunbar, Lala, Player, Rick, Marrie, Thomas J., Kojak, Clare M., Morgan, Nancy, Williams, R.Rex

“…Background: The rate of macrolide resistance among Streptococcus pneumoniae clinical isolates is rising. Coresistance to several unrelated classes of…”
Get full text

Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis by Fogarty, Charles M., Bettis, Robert B., Griffin, Timothy J., Keyserling, Constance H., Nemeth, Mary Anne, Tack, Kenneth J.

“…Patients with acute exacerbations of chronic bronchitis were treated with cefdinir 300 mg bd for 5 days or cefprozil 500 mg bd for 10 days in a prospective,…”
Get full text

Cardio- and Cerebrovascular (CCV) Safety of Once-Daily Indacaterol 75 μg in the Treatment of Patients With COPD by Donohue, James, MD, Fogarty, Charles, MD, Hu, Huilin, PhD, McBryan, Danny, MD, Williams, James, MD

Get full text

Comparison of the efficacy and safety of arformoterol 15 μg twice daily and arformoterol 30 μg once daily in COPD: A single-dose, multicenter, randomized, modified-blind, two-way crossover study by Panettieri, Reynold A., MD, MacIntyre, Neil, MD, Sims, Michael, MD, Kerwin, Edward, MD, Fogarty, Charles, MD, Noonan, Michael, MD, Claus, Raymond, MS, Andrews, William T., MD

“…Abstract Objective: The aim of this study was to compare the efficacy and safety of nebulized arformoterol 15 μg/2 mL twice daily (ARF15 BID) and 30 μg/4 mL…”
Get full text

Smoking is not a predictor of mortality and morbidity following coronary artery bypass grafting by Utley, J R, Leyland, S A, Fogarty, C M, Smith, W P, Knight, E B, Feldman, G J, Wilde, E F

“…The objective of this study was to determine the significant differences in preoperative and operative characteristics, and postoperative outcomes in patients…”
Get more information

Effect of simple anthracite pneumoconiosis on lung mechanics by Murphy, D M, Metzger, L F, Silage, D A, Fogarty, C M

“…A respiratory questionnaire was administered to 20 miners with simple anthracite coal workers' pneumoconiosis (CWP) and ten normal subjects. Lung function…”
Get more information